This Article Figures Only Full Text Full Text (PDF) View Online Appendix All Versions of this Article: j.jacc.2007.09.006v1 50/20/2002    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Beanlands, R. S.B. Search for Related Content PubMed PubMed Citation Articles by Beanlands, R. S.B. Related Collections Related Article

EXPEDITED PUBLICATION

F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease

A Randomized, Controlled Trial (PARR-2)

Rob S.B. Beanlands, MD, FRCPC, FACC^_*,_*, Graham Nichol, MD, FRCPC, Ella Huszti, MSc^¶, Dennis Humen, MD, FRCPC, FACP, FACC, Normand Racine, MD, FRCPC^#, Michael Freeman, MD, FACC, FRCPC, Karen Y. Gulenchyn, MD, FRCPC^||, Linda Garrard, BSc, RN^_*, Robert deKemp, PhD^_*, Ann Guo, MEng^_*, Terrence D. Ruddy, MD, FRCPC, FACC^_*, Francois Benard, MD, FRCPC^_**, André Lamy, MD, MHSc^||, Robert M. Iwanochko, MD, FRCPC, FACC the PARR-2 Investigators

^_* National Cardiac PET Centre, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Division of Cardiology, London Health Sciences Center, London, Ontario, Canada
Division of Cardiology, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
Division of Cardiology, Toronto Hospital, University of Toronto Health Sciences Network, Toronto, Ontario, Canada
^|| ES Garnett Memorial PET Center, Department of Nuclear Medicine and the Division of Cardiac Surgery, Hamilton Health Sciences, Hamilton, Ontario, Canada
^¶ Epidemiology and Biostatistics Department, McGill University, Montréal, Québec, Canada
^# Division of Cardiology, Montréal Heart Institute, Montréal, Québec, Canada
^_** Division of Nuclear Medicine, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Québec, Canada
University of Washington—Harborview Center for Prehospital Emergency Care, Seattle, Washington.
The PARR-2 Investigators were affiliated with the previously mentioned institutions in addition to the following: the Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, Toronto Western Hospital, University of Toronto, Ontario, Canada; Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; and the Division of Cardiology, Hopital Laval, Universitaire de Laval, Québec City, Québec, Canada.

Manuscript received July 5, 2007; revised manuscript received August 23, 2007, accepted September 7, 2007.

^_* Reprint requests and correspondence: Dr. Rob S. Beanlands, National Cardiac PET Centre, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, K1Y 4W7 Canada. (Email: rbeanlands{at}ottawaheart.ca).

Objectives: We conducted a randomized trial to assess the effectiveness of F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)-assisted management in patients with severe ventricular dysfunction and suspected coronary disease.

Background: Such patients may benefit from revascularization, but have significant perioperative morbidity and mortality. F-18-fluorodeoxyglucose PET can detect viable myocardium that might recover after revascularization.

Methods: Included were patients with severe left ventricular (LV) dysfunction and suspected coronary disease being considered for revascularization, heart failure, or transplantation work-ups or in whom PET was considered potentially useful. Patients were stratified according to recent angiography or not, then randomized to management assisted by FDG PET (n = 218) or standard care (n = 212). The primary outcome was the composite of cardiac death, myocardial infarction, or recurrent hospital stay for cardiac cause, within 1 year.

Results: At 1 year, the cumulative proportion of patients who had experienced the composite event was 30% (PET arm) versus 36% (standard arm) (relative risk 0.82, 95% confidence interval [CI] 0.59 to 1.14; p = 0.16). The hazard ratio (HR) for the composite outcome, PET versus standard care, was 0.78 (95% CI 0.58 to 1.1; p = 0.15); for patients that adhered to PET recommendations for revascularization, revascularization work-up, or neither, HR = 0.62 (95% CI 0.42 to 0.93; p = 0.019); in those without recent angiography, for cardiac death, HR = 0.4 (95% CI 0.17 to 0.96; p = 0.035).

Conclusions: This study did not demonstrate a significant reduction in cardiac events in patients with LV dysfunction and suspected coronary disease for FDG PET-assisted management versus standard care. In those who adhered to PET recommendations and in patients without recent angiography, significant benefits were observed. The utility of FDG PET is best realized in this subpopulation and when adherence to recommendations can be achieved.

Abbreviations and Acronyms   CABG = coronary artery bypass graft   CAD = coronary artery disease   CI = confidence interval   EF = ejection fraction   FDG = F-18-fluorodeoxyglucose   HR = hazard ratio   LV = left ventricle/ventricular   MI = myocardial infarction   MRI = magnetic resonance imaging   PET = positron emission tomography   RVG = radionuclide ventriculography

Related Article

Not All Randomized Trials Are Equal

K. Lance Gould
J. Am. Coll. Cardiol. 2007 50: 2013-2015. [Full Text] [PDF]

This article has been cited by other articles:

				R. Hachamovitch, B. Nutter, M. A. Hlatky, L. J. Shaw, M. L. Ridner, S. Dorbala, R. S. B. Beanlands, B. J. W. Chow, E. Branscomb, P. Chareonthaitawee, et al. Patient Management After Noninvasive Cardiac Imaging: Results From SPARC (Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease) J. Am. Coll. Cardiol., January 31, 2012; 59(5): 462 - 474. [Abstract] [Full Text] [PDF]

				M. C. Ziadi, R. A. deKemp, K. A. Williams, A. Guo, B. J. W. Chow, J. M. Renaud, T. D. Ruddy, N. Sarveswaran, R. E. Tee, and R. S. B. Beanlands Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia J. Am. Coll. Cardiol., August 9, 2011; 58(7): 740 - 748. [Abstract] [Full Text] [PDF]

				R. H. J. A. Slart, C. J. Zeebregts, H. L. Hillege, J. de Sutter, R. A. J. O. Dierckx, D. J. van Veldhuisen, F. Zijlstra, and R. A. Tio Myocardial Perfusion Reserve After a PET-Driven Revascularization Procedure: A Strong Prognostic Factor J. Nucl. Med., June 1, 2011; 52(6): 873 - 879. [Abstract] [Full Text] [PDF]

				H. Gewirtz Cardiac PET: A Versatile, Quantitative Measurement Tool for Heart Failure Management J. Am. Coll. Cardiol. Img., March 1, 2011; 4(3): 292 - 302. [Abstract] [Full Text] [PDF]

				L. M. Mielniczuk, D. Birnie, M. C. Ziadi, R. A. deKemp, J. N. DaSilva, I. Burwash, A. T. Tang, R. A. Davies, H. Haddad, A. Guo, et al. Relation Between Right Ventricular Function and Increased Right Ventricular [18F]Fluorodeoxyglucose Accumulation in Patients With Heart Failure Circ Cardiovasc Imaging, January 1, 2011; 4(1): 59 - 66. [Abstract] [Full Text] [PDF]

				D. P. Leong, P. L. Madsen, and J. B. Selvanayagam Non-invasive evaluation of myocardial fibrosis: implications for the clinician Heart, December 15, 2010; 96(24): 2016 - 2024. [Full Text] [PDF]

				N. Ghosh, O. E. Rimoldi, R. S. B. Beanlands, and P. G. Camici Assessment of myocardial ischaemia and viability: role of positron emission tomography Eur. Heart J., December 2, 2010; 31(24): 2984 - 2995. [Abstract] [Full Text] [PDF]

				P. G. Camici Advances in SPECT and PET for the management of heart failure Heart, December 1, 2010; 96(23): 1932 - 1937. [Full Text] [PDF]

				Developed with the special contribution of the Eur, Authors/Task Force Members, W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J., October 2, 2010; 31(20): 2501 - 2555. [Full Text] [PDF]

				The Task Force on Myocardial Revascularization of Guidelines on myocardial revascularization Eur J Cardiothorac Surg, September 1, 2010; 38(Supplement_1): S1 - S52. [Full Text] [PDF]

				R. J. Gropler, R. S. B. Beanlands, V. Dilsizian, E. D. Lewandowski, F. S. Villanueva, and M. C. Ziadi Imaging Myocardial Metabolic Remodeling J. Nucl. Med., May 1, 2010; 51(Supplement_1): 88S - 101S. [Abstract] [Full Text] [PDF]

				A. Abraham, G. Nichol, K. A. Williams, A. Guo, R. A. deKemp, L. Garrard, R. A. Davies, L. Duchesne, H. Haddad, B. Chow, et al. 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial J. Nucl. Med., April 1, 2010; 51(4): 567 - 574. [Abstract] [Full Text] [PDF]

				K. C. Allman 18F-FDG PET and Myocardial Viability Assessment: Trials and Tribulations J. Nucl. Med., April 1, 2010; 51(4): 505 - 506. [Full Text] [PDF]

				G. D'Egidio, G. Nichol, K. A. Williams, A. Guo, L. Garrard, R. deKemp, T. D. Ruddy, J. DaSilva, D. Humen, K. Y. Gulenchyn, et al. Increasing Benefit From Revascularization Is Associated With Increasing Amounts of Myocardial Hibernation: A Substudy of the PARR-2 Trial J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1060 - 1068. [Abstract] [Full Text] [PDF]

				G. A. Beller and L. P. Budge Viable: Yes, No, or Somewhere in the Middle? J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1069 - 1071. [Full Text] [PDF]

				F. M. Bengel, T. Higuchi, M. S. Javadi, and R. Lautamaki Cardiac Positron Emission Tomography J. Am. Coll. Cardiol., June 30, 2009; 54(1): 1 - 15. [Abstract] [Full Text] [PDF]

				R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70. [Full Text] [PDF]

				R. Hachamovitch and M. F. Di Carli Methods and Limitations of Assessing New Noninvasive Tests: Part II: Outcomes-Based Validation and Reliability Assessment of Noninvasive Testing Circulation, May 27, 2008; 117(21): 2793 - 2801. [Full Text] [PDF]

				A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al. Highlights of the Year in JACC 2007 J. Am. Coll. Cardiol., January 29, 2008; 51(4): 490 - 512. [Full Text] [PDF]

				K. L. Gould Not All Randomized Trials Are Equal J. Am. Coll. Cardiol., November 13, 2007; 50(20): 2013 - 2015. [Full Text] [PDF]